Home › Anaplastic Large-Cell Lymphoma › Ohio
Anaplastic Large-Cell Lymphoma clinical trials in Ohio
3 studies for Anaplastic Large-Cell Lymphoma are looking for participants at sites in Ohio.
Cities in Ohio
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- The Ohio State University, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- OhioHealth O'Bleness Hospital, Athens
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- and 10 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06724237A Registry for People With T-cell Lymphoma
- Ohio State University (Data Collection Only), Columbus
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.